Amid surging popularity and shortages of popular weight-loss drugs, some patients are turning to cheaper, compounded versions of the drugs. The concern is that patients may not necessarily know what ...

Following disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market. In a statement issued Friday, Amylyx Pharmaceuticals said that Relyvrio failed to ...